The Meridian Dispatch.

The editor's brief, vintage alerts, and methodology updates, three named streams, each opt-in, each useful in a different way. Read by sector analysts, corporate-development teams, and editors at sister publications.

One email. Three streams. Pick the ones you want.

Subscribing creates a free reader account so you can manage which streams you receive from one place. You can change your preferences or unsubscribe entirely from any email or from /account/notifications.

Free. No paywall, no upsell sequences, no ‘upgrade for the full essay’.
No advertising. Nobody pays to be in the email.
No data resale. Your address is not shared with any third party for marketing.
One-click unsubscribe in every email. We honour the unsubscribe permanently.
Plain text and image-light. Renders on every client.

The three streams

What each one delivers.

Weekly · Sunday morning

Editor's brief

The Editorial Committee's read on what shifted in the previous week. Five paragraphs maximum, curated rather than comprehensive. The closest thing in our publishing schedule to a recommendation.

Three sector signals worth flagging
One methodology note when standards change
One named figure refresh from the catalogue

Per-report · only on the markets you watch

Vintage alerts

When a market on your watchlist refreshes, scheduled or event-triggered, you receive a one-paragraph summary of what changed, the prior figure, the new figure, and the trigger event. No digest; one email per refresh.

Material correction notices, in your inbox first
Refresh-trigger event named in every alert
One-click unwatch from the email footer

Quarterly · or when standards change

Methodology updates

When the source hierarchy changes, when a new evidence class is added, when the corrections protocol updates. Editorial-standard changes are dated and the rationale is published alongside.

Diff of the standards before and after
Rationale for the change, with examples
Effective date and which reports it affects

Sample issue

What the editor's brief reads like.

VOL. 01 · ISSUE 04 · SUNDAY

The Meridian Dispatch

From the Meridian Consensus Editorial Committee

Three things shifted in the catalogue this week. Two are sector-specific; one is methodological and applies across every report we publish.

First, the GLP-1 receptor-agonist sector saw a vintage refresh triggered by Q1 earnings. The headline TAM moved from $58B to $61.4B; the divergence between our three evidence paths narrowed by 8%. The full revision note is filed at /markets/glp-1-receptor-agonists/revisions.

Second, EV battery: a regulatory action in the EU is the kind of event that triggers an early refresh under our standards rather than waiting for the 90-day cadence. Look for that report to update by mid-week.

Third, and this is the methodological note, we've added an evidence sub-class for ‘regulatory guidance documents’ below the regulatory-filing tier. The rationale is published at /methodology and dated. No prior figures change as a result; the change applies to the next vintage of every published report.

, M.E.

You're reading a sample. Subscribe above to receive the next issue.

Privacy footing

Your email is stored to deliver the streams you've opted into and nothing else. Subscriber lists are not shared, sold, or used for advertising. Full detail in the privacy policy. Already subscribed? Manage preferences at /account/notifications.